• Registration, Cancellation policy, Scholarships
  • Auditorium Maximum UJ

Goal

To provide updated diagnostically relevant information on predominantly immunohistochemical markers, useful antibodies, optimal clones and optimal antibody panels applicable in…

Read More

Speakers

(in alphabetical order) will be announced soon

Read More

Organizing / Scientific Committee

Course Director: Janusz Ryś MD. PhD. Members: Agnieszka Adamczyk PhD.Artur Bartczak MD.Agnieszka Klimkowska PhD.Jan Klos MD.Artur Kowalik PhD.Anna Kruczak PhD.Krzysztof…

Read More

Language, Participants

Language: The language of the course is English. Participants: The target groups are consultant pathologists and pathologists in training. The…

Read More

Venue, Travel, Contact

Auditorium Maximum of the Jagiellonian UniversityKrupnicza 33, Kraków(9-11th April 2025) Travel The old city of Krakow is a tourist attraction…

Read More
Read More

Program

  • 09.00 – 10.00

    Registration and coffee

  • 10.00 – 10.15

    Janusz Ryś – Introduction

  • 10.15 – 11.00

    Søren Nielsen – Immunohistochemical technology in preanalytical and analytical phase

  • 11.00 – 11.45

    Jan Klos – IHC – Interpretation pitfalls – old problems and new aspects

  • 11.45 – 12.30

    Andrew M. Bellizzi – Immunohistochemical approach to unknown primary tumor

  • 12.30 – 13.30

    Lunch

  • 13.30 – 17.00

    Sesion 2: Molecular Diagnostics in Clinical Practice: Bridging Science and Personalized Cancer Care

  • 13.30 – 14.15

    Hans-Ulrich Schildhaus – New predictive immunohistochemical and molecular markers for solid tumors

  • 14.15 – 15.00

    Hans Gelderblom – Study Design with Molecular Prescreening and Targeted Therapies in Oncology

  • 15.00 – 15.30

    Coffee

  • 15.30 – 16.15

    Susana Aguilar – Organizing and Optimizing Molecular Tumour Boards for Precision Oncology

  • 16.15 – 17.00

    Kjetil Taskén – The National Norwegian Model: Best Practices in Innovative Molecular Diagnostics and Tailored Therapies

  • 17.00 – 17.30

    Discussion

  • 08.30 – 10.45

    Sesion 3: Gynaecological session

  • 08.30 – 09.15

    Anais Malpica – Ovarian Neoplasms: Immunohistochemical Studies and Molecular Testing, What and Why?

  • 09.15 – 10.00

    Ben Davidson – Morphological and molecular characteristics of endometrial carcinoma

  • 10.00 – 10.45

    Pavel Dundr – Diagnostic approach to smooth muscle uterine tumors.

  • 10.45 – 11.15

    Coffee

  • 11.15 – 12.45

    Sesion 4: Lymphoproliferative disease

  • 11.15 – 12.00

    Anna Porwit – Immunohistochemical and molecular approaches to diagnostics of B-cell lymphomas

  • 12.00 – 12.45

    Anna Porwit – Immunohistochemical and molecular approaches to diagnostics of T-cell lymphomas

  • 12.45 – 13.30

    Lunch

  • 13.30 – 16.15

    Sesion 4: Dermatopathology session

  • 13.30 – 14.15

    Thomas Mentzel – Update on cutaneous sarcomas (the role of immunohistochemistry in differential diagnostics)

  • 14.15 – 15.00

    Thomas Mentzel – Immunohistochemistry in melanocytic neoplasms

  • 15.00 – 16.15

    Monika Prochorec-Sobieszek – Lymphoproliferative lesions of the skin – immunohistochemical and molecular approach

  • 16.15 – 16.45

    Coffee

  • 16.45 – 18.00

    Consultation corner (10-12 cases) (A. Malpica, B. Davidson, T. Mentzel, A. Porwit, M. Miettinen)

  • 08.30 – 10.30

    Sesion 5: Gastrointestinal session

  • 08.30 – 09.15

    Andrzej Mróz – Gastric cancereveryday practice and future perspectives in diagnostic pathology

  • 09.15 – 10.00

    Iris Nagtegaal – The central role of mismatch repair proteins in colorectal cancer pathology

  • 10.00 – 10.30

    Regine Schneider-Stock – Colorectal cancerdissolving heterogeneity between tumor center and invasion front using the CAM model

  • 10.30 – 11.00

    Coffee

  • 11.00 – 13.00

    Sesion 6: Molecular and soft tissue session

  • 11.00 – 11.30

    Beata Grygalewicz – FISH studies for the detection of malignant lymphoma-associated chromosomal changes in fresh material and paraffin-embedded tissue

  • 11.30 – 12.15

    Jerzy Lasota – The spectrum of EWSR1-fusion tumors: Ewing sarcoma and beyon

  • 12.15 – 13.00

    Markku Miettinen – DNA Methylation Classifier in Sarcoma Diagnosis – Current status and prospects

  • 13.00 – 13.45

    Lunch

  • 13.45 – 15.00

    Sesion 7: Digital pathology and AI in Clinical Practice and Research

  • 13.45 – 14.15

    Konstanty Korski – Current and future applications of artificial intelligence in pathology

  • 14.15 – 15.00

    Anna Laury – Artificial Intelligence-base image analysis and prognosis of high-grade serous carcinoma

  • 15.00

    Summary and closing remarks